Generation and neutralization of pseudovirions of human papillomavirus type 33.
about
The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptorsHuman papillomavirus infection requires cell surface heparan sulfate.A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virionsThe l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNACharacterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitopeThe cytoskeleton in papillomavirus infectionBovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationHuman papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses.Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16.Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.Assembly and translocation of papillomavirus capsid proteins.Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1.Cell surface-binding motifs of L2 that facilitate papillomavirus infection.Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implicationsDetection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsA Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome PackagingProduction of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells.The evolving field of human papillomavirus receptor research: a review of binding and entry.Efficient intracellular assembly of papillomaviral vectorsL2, the minor capsid protein of papillomavirus.Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding.Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process.
P2860
Q24309388-E3C3FDF9-7FC4-4FDB-8EF8-553D5E40B5DCQ24529079-A960423F-154A-4F71-9441-CF2405DEB628Q24537580-8C104B43-7285-47BF-A041-E3364128FCC3Q24646183-56239650-8A8C-42C6-B646-C1325605F2B3Q24674159-462FC99A-BD7C-4B42-9592-250A1252B1B2Q24796150-109FC684-BDA3-4A77-892D-0AB74E51DFF9Q26861667-C6A58198-EE34-43E9-8F0B-4ABF0462DE83Q28593400-0FC98527-50D5-4FE5-AE7F-B192E940BC24Q33514126-3E36429A-9903-41FE-B6A6-4AF65263C4E3Q33652425-798FCEF5-27A9-49A0-A764-77E148B9A440Q33673620-550EEF33-7019-4BA4-8CCF-106FD869561FQ33786402-069ACA58-0683-410F-A4AF-7EAC842F4995Q33787204-171B87D1-457A-4C47-8B8A-D707C483E9E6Q33816200-3056E5C7-3EF9-467F-9247-A5FE3CBBCC49Q33839721-FD560A70-6C48-4F74-AE51-B547080E6000Q33840918-8A12FBEF-3E16-4D13-8BA1-D5D10402FAB8Q33847557-384F2049-3C4F-463C-B965-1D52F048D74EQ33848323-62E09B0E-DBFC-49CC-88F8-34CAB346CDDEQ33850734-01C481A2-1CD6-4923-AC68-4A40E4E17CE6Q33950282-C09705E2-5665-48B7-912C-1CE87B3DE1E0Q34069054-3D874075-A0DB-4C5F-8268-F7F9CD163899Q34075698-53038861-1CDD-4090-B637-2CB8F11702A5Q34227402-D7DE0A74-ACEE-47A8-9F5D-2B58A8C620ACQ34347720-E6864703-949A-43BC-B2B1-1A491380CC0DQ34360259-77504398-1F76-49A0-BD2E-AFE5E96B363FQ34743921-F9DC5185-1EAB-4D98-A982-E232DEED43C5Q35079915-88FA171F-C4BE-4FAF-B3D1-71F4079DFB30Q35887709-AB200A98-C7A0-4150-AB6F-8EE2194A0A3BQ36086288-E66D805A-74B5-4ECB-88D1-0CF8AD385260Q36099326-55753A01-AEA2-4463-96C3-7D5C52FC3931Q36253322-69185637-C098-4065-9096-435F276E4E57Q36422554-7636273F-096F-4D58-86EB-0702E1CFF45BQ36434185-05BEF176-4F3B-4E8A-98EF-F977A8B5D453Q36555514-5848F85D-4FA8-4DE7-80BE-E49C797F8F44Q36827213-33A8F3CE-311C-4FF0-BC15-34E9A5910DF5Q36944399-F41825C1-1588-4FF1-82D1-42CEC812C1EDQ37164879-DA3BE509-504A-4D70-B7E1-800BDB5DA3A4Q37480444-5D72BBD6-9770-4FB9-9265-0CE7D28DFB92Q37683446-71016E83-5937-4F1C-84BC-F160983BCAF8Q38752656-BA72C59E-90A4-4FA3-ABC6-27B51D1B3567
P2860
Generation and neutralization of pseudovirions of human papillomavirus type 33.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@en
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@nl
type
label
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@en
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@nl
prefLabel
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@en
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@nl
P2093
P2860
P1433
P1476
Generation and neutralization of pseudovirions of human papillomavirus type 33.
@en
P2093
P2860
P304
P407
P577
1997-04-01T00:00:00Z